Mass tort firms are navigating two competing realities: (1) claimant volume can surge overnight, and (2) eligibility often hinges on detailed exposure, product usage, medical timelines, and documentation that don’t fit neatly into a single “yes/no” form. That mismatch...
How AI Is Transforming Mass Tort Case Review and Eligibility Screening for Plaintiffs’ Firms
read more
